9-ING-41
| Supplier | MedChemExpress |
|---|---|
| Product # | HY-113914-50 mg |
| CAS # | 1034895-42-5 |
| Pricing | 50 mg, USD $750.0 |
| Biological Activity | 9-ING-41 is a maleimide-based ATP-competitive and selective glycogen synthase kinase-3β (GSK-3β) inhibitor with an IC50 of 0.71 μM. 9-ING-41 significantly leads to cell cycle arrest, autophagy and apoptosis in cancer cells. 9-ING-41 has anticancer activity and has the potential for enhancing the antitumor effects of chemotherapeutic drugs[1][2][3][4]. |
| Purity | 99.32% |
| MWt | 404.35 |
| Formula | C₂₂H₁₃FN₂O₅ |